Guiqi Zhu
11PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jul 22, 2025
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma.Tianhao Chu, Guiqi Zhu, Zheng Tang
|May 02, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.Wei-Feng Qu, Gui-Qi Zhu, Rui Yang
|Jan 21, 2025
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.Gui-Qi Zhu, Zheng Tang, Tian-Hao Chu
|Nov 04, 2024
Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma.Shiping Chen, Peiling Zhang, Guiqi Zhu
|Sep 03, 2024
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma.Jialiang Cai, Lina Song, Feng Zhang
|Dec 24, 2023
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma.Weiren Liu, Huqiang Wang, Qianfu Zhao
Pageof 2
